CA2982508A1 - Means for diagnosing, predicting or monitoring pneumocystis pneumonia - Google Patents

Means for diagnosing, predicting or monitoring pneumocystis pneumonia Download PDF

Info

Publication number
CA2982508A1
CA2982508A1 CA2982508A CA2982508A CA2982508A1 CA 2982508 A1 CA2982508 A1 CA 2982508A1 CA 2982508 A CA2982508 A CA 2982508A CA 2982508 A CA2982508 A CA 2982508A CA 2982508 A1 CA2982508 A1 CA 2982508A1
Authority
CA
Canada
Prior art keywords
jirovecii
gene
seq
mitochondrial
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2982508A
Other languages
English (en)
French (fr)
Inventor
Alexandre Alanio
Stephane Bretagne
Francoise Dromer
Aude STURNY-LECLERE
Benjamin HOMMEL
Marion BENAZRA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Universite Paris Cite
Institut Pasteur
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Universite Paris Diderot Paris 7
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Universite Paris Diderot Paris 7, Institut Pasteur filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of CA2982508A1 publication Critical patent/CA2982508A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA2982508A 2015-04-15 2016-04-15 Means for diagnosing, predicting or monitoring pneumocystis pneumonia Abandoned CA2982508A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305562.9 2015-04-15
EP15305562 2015-04-15
PCT/EP2016/058355 WO2016166287A1 (en) 2015-04-15 2016-04-15 Means for diagnosing, predicting or monitoring pneumocystis pneumonia

Publications (1)

Publication Number Publication Date
CA2982508A1 true CA2982508A1 (en) 2016-10-20

Family

ID=52946502

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2982508A Abandoned CA2982508A1 (en) 2015-04-15 2016-04-15 Means for diagnosing, predicting or monitoring pneumocystis pneumonia

Country Status (7)

Country Link
US (2) US11236390B2 (https=)
EP (1) EP3283643B8 (https=)
JP (1) JP7072385B2 (https=)
CN (1) CN107636172B (https=)
CA (1) CA2982508A1 (https=)
DK (1) DK3283643T3 (https=)
WO (1) WO2016166287A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60239271D1 (de) * 2001-05-08 2011-04-07 Shima Seiki Mfg Verfahren zum herstellen strickware mit bund auf eine flachstrickmaschine
DK3283643T3 (da) * 2015-04-15 2020-05-18 Pasteur Institut Midler til diagnosticering, forudsigelse eller monitorering af Pneumocystis pneumoni
CN107354221A (zh) * 2017-08-28 2017-11-17 合肥千麦医学检验所有限公司 耶氏肺孢子菌的pcr检测试剂盒
KR102026553B1 (ko) * 2018-01-08 2019-09-27 조선대학교산학협력단 다복제유전자를 이용한 쯔쯔가무시병의 진단방법
CN109251992A (zh) * 2018-09-13 2019-01-22 昆明医科大学第附属医院 一种检测耶氏肺孢子菌的lamp引物组合物和方法
CN109346174A (zh) * 2018-10-24 2019-02-15 南昌大学第二附属医院 非人类免疫性缺陷病毒感染患者pcp风险评估系统
CN109666755A (zh) * 2018-12-25 2019-04-23 北京卓诚惠生生物科技股份有限公司 用于检测侵袭性真菌的核酸试剂、试剂盒、系统及方法
CN110408717A (zh) * 2019-07-23 2019-11-05 四川省农业科学院生物技术核技术研究所 灵芝属线粒体rns基因的特异扩增引物及其应用
WO2021039540A1 (ja) * 2019-08-23 2021-03-04 富士フイルム和光純薬株式会社 ニューモシスチス・イロベチイ検出用プライマー対、これを用いたニューモシスチス・イロベチイの検出方法及びそのための試薬キット
CN111424101A (zh) * 2020-03-30 2020-07-17 广州市第八人民医院 一种用于定量检测耶氏肺孢子菌的试剂盒和方法
CN111455094B (zh) * 2020-06-17 2020-09-08 圣湘生物科技股份有限公司 检测深部感染真菌的组合物、试剂盒、用途及其方法
CN113088579B (zh) * 2021-03-16 2022-03-22 广州医科大学附属第一医院 一种用于定性检测耶氏肺孢子菌的试剂盒和方法
ES2933149A1 (es) * 2021-07-28 2023-02-01 Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunitat Valenciana Fisabio METODO in vitro PARA EL DIAGNOSTICO DE UNA INFECCION POR Pneumocystis jirovecii
CN115029471A (zh) * 2022-05-27 2022-09-09 大连干细胞与精准医学创新研究院 一种基于数字pcr技术检测耶氏肺孢子菌的试剂盒及检测方法
CN115820921B (zh) * 2022-12-19 2024-07-05 领航基因科技（杭州）有限公司 三种肺侵袭性真菌检测的引物探针组合及其数字pcr试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189676A1 (en) * 2008-10-03 2011-08-04 Hall Thomas A Compositions for use in identification of fungi
WO2014071946A1 (en) * 2012-11-07 2014-05-15 Statens Serum Institut Diagnostic pcr primers enabling exhaustive detection of non-human eukaryotic ssu rdna in human clinical samples
DK3283643T3 (da) * 2015-04-15 2020-05-18 Pasteur Institut Midler til diagnosticering, forudsigelse eller monitorering af Pneumocystis pneumoni

Also Published As

Publication number Publication date
JP7072385B2 (ja) 2022-05-20
WO2016166287A1 (en) 2016-10-20
EP3283643B8 (en) 2020-06-10
US20180127825A1 (en) 2018-05-10
JP2018511339A (ja) 2018-04-26
US11236390B2 (en) 2022-02-01
DK3283643T3 (da) 2020-05-18
EP3283643B1 (en) 2020-04-15
EP3283643A1 (en) 2018-02-21
CN107636172A (zh) 2018-01-26
CN107636172B (zh) 2021-11-16
US20220119886A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
US20220119886A1 (en) Means for diagnosing, predicting or monitoring pneumocystis pneumonia
US9758828B2 (en) Methods to detect, treat and prevent acute cellular rejection in kidney allografts
Sanjuan-Jimenez et al. Lessons learned with molecular methods targeting the BCSP-31 membrane protein for diagnosis of human brucellosis
Shipitsyna et al. Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia
Zou et al. Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis
CA3124497A1 (en) Mitochondrial dna deletions associated with endometriosis
CN107586862A (zh) 肠道菌群在儿童反复呼吸道感染诊断中的应用
CN111455094B (zh) 检测深部感染真菌的组合物、试剂盒、用途及其方法
Moreira et al. Elevated transrenal DNA (cell-free urine DNA) in patients with urinary tract infection compared to healthy controls
JP2021500921A (ja) Ｆｉｍｈ遮断剤の治療効率を評価するための新規ツール
CN111020042B (zh) 检测a族链球菌的组合物及方法
WO2022009988A1 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
WO2023021978A1 (ja) 自己免疫疾患を検査する方法
JP2023020631A (ja) 全身性エリテマトーデスを検査する方法
CN114480636A (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
JP2022025456A (ja) 多発性硬化症を検査する方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
CN112575078A (zh) lncRNAs作为活动性肺结核病特异性标志物的应用
WO2021039777A1 (ja) 関節リウマチを検査する方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP5435612B2 (ja) リケッチア・ジャポニカ感染症の診断方法
KR20110116644A (ko) 결핵의 진단을 위한 정보제공방법 및 이를 위한 결핵 진단용 키트
WO2019062429A1 (zh) 分子标记物tcons_00016233、试剂盒及应用
CN118773308A (zh) 一种筛查高原适应性的微小核酸分子生物标志物及其应用

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210413

FZDE Discontinued

Effective date: 20230802